Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results
    • Narayana Hrudayalaya...

    Narayana Hrudayalaya Q1 net profit slips 36% to Rs 11 crore

    Written by Ruby Khatun Khatun Published On 2017-08-05T09:30:23+05:30  |  Updated On 5 Aug 2017 9:30 AM IST
    Narayana Hrudayalaya Q1 net profit slips 36% to Rs 11 crore

    Mumbai: Narayana Hrudayalaya Ltd reported a 36 per cent decline in net profit at Rs 10.9 crore in the first quarter ended June 30 from Rs 17.2 crore in the same period last year.


    The net profit after minority interest and share of loss in associates stood at Rs 10.9 crore as compared to Rs 17.2 crore in Q1 FY17, the healthcare service provider said in a release here.


    Consolidated total operating income was Rs 521.1 crore in Q1 FY18 as against Rs 452 crore in Q1 FY17, reflecting an increase of 15.3 per cent. Consolidated EBITDA stood at Rs 55.6 crore, reflecting a margin of 10.7 per cent as against Rs 55.9 crore in Q1 FY17, the release said.


    As on June 2017, the consolidated net debt was Rs 283.9 crore representing a net debt to equity ratio of 0.29.


    The company has commissioned 207-bedded SRCC Narayana Hospital at Haji Ali in Mumbai which is a one-of-its kind paediatric facility. It has also acquired a near-complete 230- bedded hospital in Gurugram which is expected to be commissioned in the next seven months, it said.


    "Our performance this quarter is in line with our expectation amidst the unpredictable and challenging regulatory environment whose effects we foresee to continue over the near to medium term.


    "While there has been an impact due to curb on cardiac stent pricing along with commissioning of our new facility in Mumbai, we remain on-track to deliver affordable quality healthcare to all with our business model," said Narayana Hrudayalaya managing director Ashutosh Raghuvanshi.


    "Overall, we believe that our long-term growth potential remains intact as Indian healthcare sector is undergoing a major overhaul providing us with plethora of opportunities," Raghuvanshi said.

    Ashutosh RaghuvanshiConsolidated total operating incomedeclinefirst quarterHaji AliHealthcaremarginsNarayana HrudayalayaNarayana Hrudayalaya Ltdnet profitSRCC Narayana Hospita
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok